These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16118343)

  • 61. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.
    Wang CY; Chang TC
    J Formos Med Assoc; 2001 Nov; 100(11):753-7. PubMed ID: 11802534
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlation between colored Doppler echography of fetal thyroid goiters and histologic study.
    Ceccaldi PF; Cohen S; Vuillard E; Guimiot F; Delezoide AL; Poujade O; Ducarme G; Oury JF; Luton D
    Fetal Diagn Ther; 2010; 27(4):233-5. PubMed ID: 20516655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Different Forms of Hypothyroidism in Infants with Maternal Graves' Disease: A Case Series.
    Lordudass AAD; Wong JSL; Selveindran N; Hong JYH
    J ASEAN Fed Endocr Soc; 2024; 39(1):120-124. PubMed ID: 38863905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The fetus in maternal hyperthyroidism.
    Perelman AH; Clemons RD
    Thyroid; 1992; 2(3):225-8. PubMed ID: 1422235
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis.
    Bando Y; Nagai Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
    Thyroid; 1999 Feb; 9(2):183-7. PubMed ID: 10090320
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
    Kubota S; Takata K; Arishima T; Ohye H; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Miyauchi A
    Thyroid; 2008 Jan; 18(1):63-6. PubMed ID: 18302519
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
    Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk factors for developmental disorders in infants born to women with Graves disease.
    Mitsuda N; Tamaki H; Amino N; Hosono T; Miyai K; Tanizawa O
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):359-64. PubMed ID: 1379702
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Graves' hyperthyroidism in pregnancy.
    Nguyen CT; Mestman JH
    Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):232-240. PubMed ID: 31389810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The usefulness of thyroid size and TSH receptor antibody (TRAb) determinations in predicting the effectiveness of tiamazole and I-131 treatment for Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):242-7. PubMed ID: 15314993
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thyroid disorders during pregnancy: impact on the fetus.
    Polak M
    Horm Res Paediatr; 2011; 76 Suppl 1():97-101. PubMed ID: 21778758
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A case of fetal hyperthyroidism treated with maternal administration of methimazole.
    Sato Y; Murata M; Sasahara J; Hayashi S; Ishii K; Mitsuda N
    J Perinatol; 2014 Dec; 34(12):945-7. PubMed ID: 25421129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.